Skip to content

RaySearch Laboratories delivers an intermediate financial update

Increased sales, albeit slightly, resulted in reduced operating and tax profits.

RaySearch Laboratories releases preliminary findings
RaySearch Laboratories releases preliminary findings

RaySearch Laboratories delivers an intermediate financial update

In the dynamic world of healthcare technology, RaySearch Laboratories, a renowned provider of radiation therapy clinic software based in Stockholm, Sweden, has announced its financial results for the second quarter of 2025. The company, known for its innovative solutions, has also entered into a collaboration with Advanced Radiation Therapeutics in San Luis Obispo, CA.

The collaboration with Advanced Radiation Therapeutics marks a significant step for RaySearch, as the company aims to equip the Californian facility with its cutting-edge software. This strategic partnership is expected to strengthen RaySearch's presence in the US market.

However, the financial results for the same period paint a mixed picture. RaySearch reported a 10.5% increase in net sales for the quarter, totalling 636.6 million Swedish kronor, equivalent to approximately $66.5 million U.S. Despite this growth, the operating profit for the quarter stood at 111.2 million Swedish kronor, or $11.6 million.

On closer inspection, it appears that the growth in net sales was not evenly distributed. While the company saw a 10.5% increase in overall sales, the second quarter saw a 4.4% decrease compared to the previous quarter. This downward trend in quarter-on-quarter sales may be a cause for concern for some investors.

RaySearch's profit after tax for the half-year 2025 showed a 11% decrease from the same period last year, amounting to 87.6 million Swedish kronor, or $9.2 million. Furthermore, the company reported a 17% decrease in order intake for the second quarter, amounting to 241.2 million Swedish kronor, or $25.2 million.

Despite these challenges, RaySearch remains optimistic about its future prospects. The collaboration with Advanced Radiation Therapeutics is a testament to the company's commitment to delivering innovative solutions in the field of radiation therapy. As the company continues to grow and adapt, it will be interesting to see how it navigates these financial challenges and leverages its partnerships to drive growth in the coming quarters.

Read also: